46 Stocks Moving In Friday's Mid-Day Session



  • Kanzhun Limited BZ shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share.
  • Novan, Inc. NOVN shares jumped 73.3% to $15.67 after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primary endpoint and no serious adverse events were reported.
  • Janux Therapeutics, Inc. JANX gained 46.7% to $24.93 as the company priced its IPO at $17 per share.
  • Urban One, Inc. UONE gained 37.1% to $21.19, amid a continued run up into Juneteenth, during which the stock saw a surge last year.
  • Iconix Brand Group, Inc. ICON surged 27.7% to $3.13.
  • TaskUs, Inc TASK gained 26.8% to $29.17 after the company priced its IPO at $23 per share.
  • Aptinyx Inc. APTX shares climbed 24.8% to $4.0050 on continued strength. The stock spiked Thursday after traders circulate a TipRanks titled '2 "Strong Buy" Penny Stocks That Could Rally to $10 (or More)' mentioning the stock.
  • GBS Inc. GBS rose 24.5% to $4.52 after jumping around 19% on Thursday.
  • Vaxart, Inc. VXRT gained 22.3% to $8.77 after Piper Sandler initiated coverage on the stock with an Overweight rating and $18 price target.
  • Cassava Sciences, Inc. SAVA rose 19.1% to $79.02. Cassava Sciences shares traded higher on Monday following FDA approval for Biogen's Alzheimer's candidate.
  • Carver Bancorp, Inc. CARV gained 20.3% to $14.96 amid a continued run up into Juneteenth, during which the stock saw a surge last year.
  • Amesite Inc. AMST rose 18.6% to $3.2850 after surging over 25% on Thursday.
  • Broadway Financial Corporation BYFC gained 18.3% to $3.02.
  • Xinyuan Real Estate Co., Ltd. XIN gained 17.7% to $3.45. Xinyuan Real Estate shares gained 14% on Thursday after the company highlighted completion of five newly constructed properties.
  • Protagonist Therapeutics, Inc. PTGX gained 17.5% to $39.76 after the company announced updated results from the ongoing Phase 2 study of rusfertide at the European Hematology Association 2021 Virtual Congress.
  • Apollo Medical Holdings, Inc. AMEH surged 17.5% to $47.25 after it was announced the company is set to join the S&P SmallCap 600.
  • AcuityAds Holdings Inc. ATY gained 15.2% to $11.77. The company priced its IPO at $10.15 per share.
  • Chemomab Therapeutics Ltd. CMMB rose 14.6% to $22.92 after gaining around 4% on Thursday.
  • Siebert Financial Corp. SIEB gained 14.7% to $5.31.
  • Annovis Bio, Inc. ANVS jumped 14% to $88.76. Annovis Bio recently announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which has a potential role in developing Alzheimer's Disease.
  • Synaptogenix, Inc. SNPX gained 12.5% to $9.00. Synaptogenix recently announced an update on its ongoing National Institutes of Health (NIH) sponsored Phase 2b trial of Bryostatin-1 for moderately severe Alzheimer's disease (AD).
  • Senseonics Holdings, Inc. SENS rose 11.9% to $4.05 after jumping 18% on Thursday.
  • Protagenic Therapeutics, Inc. PTIX rose 9% to $2.91 after jumping over 13% on Thursday. Recently, the company’s S-3 filing showed registration for a $100 million mixed securities shelf offering.
  • Precigen, Inc. PGEN shares rose 5% to $7.34 after the company announced the primary endpoint of both the Phase 1b AG019 monotherapy and the Phase 2a AG019 combination therapy was met from the Phase 1b/2a study of AG019 ActoBiotics.

Check out these big penny stock gainers and losers


  • Recon Technology, Ltd. RCON shares dipped 58% to $5.35.
  • Recon Technology reports its Beijing BHD Petrolume subsidiary signed 2 contracts with Sinopec's North China E&P Co.
  • Orphazyme A/S ORPH fell 51% to $10.31 after jumping 302% on Thursday. On May 7, in the latest press statement put out by Orphazyme, it said its application for arimoclomol, which will be branded as MIPLYFFA for Niemann-Pick disease type C, is under priority review with the U.S. Food and Drug Administration — with the expected Prescription Drug User Fee Act action date of June 17.
  • Curis, Inc. CRIS dipped 36.1% to $8.11 after the company announced updated data from its ongoing Phase 1/2 open-label, single arm, dose escalation and expansion trial of CA-4948.
  • Aptose Biosciences Inc. APTO dropped 30.7% to $3.83 after the company released highlights from its Luxeptinib clinical program.
  • Galecto, Inc. GLTO shares fell 26.5% to $5.88 after surging 60% on Thursday.
  • TRxADE HEALTH, Inc. MEDS shares fell 24.1% to $5.06. Trxade Health shares climbed 63% on Thursday after the company announced the launch of its MedCheks health passport app for iOS devices.
  • Heat Biologics, Inc. HTBX shares fell 23.5% to $7.33. Heat Biologics shares surged 40% on Thursday after the company filed for a patent titled “GP96-Based Cancer Therapy.”
  • Antelope Enterprise Holdings Limited AEHL dropped 22.2% to $3.19 after the company announced pricing of a registered direct offering.
  • Sphere 3D Corp. ANY fell 21.2% to $2.5301. Sphere 3D shares surged over 60% on Thursday on continued strength after the company and Gryphon Digital on Wednesday announced an agreement to purchase 250,000 Certified Emission Reductions.
  • Forma Therapeutics Holdings, Inc. FMTX dipped 19.4% to $22.61 after the company highlighted the presentation of new Phase 1 data on etavopivat at the European Hematology Association 2021 Virtual Congress.
  • Puhui Wealth Investment Management Co., Ltd. PHCF fell 17.3% to $4.36.
  • Medley Management Inc. MDLY shares fell 16.9% to $6.64. Medley Management shares jumped around 37% on Thursday as retail traders pushed the stock higher.
  • Qumu Corporation QUMU dipped 14.5% to $3.95 after Craig-Hallum downgraded the stock from Buy to Hold and announced a $6 price target.
  • Biomerica, Inc. BMRA fell 14.5% to $3.96.
  • Cheetah Mobile Inc. CMCM dropped 14.5% to $2.36 after the company reported a sharp decline in quarterly sales.
  • Loop Industries, Inc. LOOP fell 14.4% to $11.77.
  • ZIVO Bioscience, Inc. ZIVO fell 13.3% to $4.5190 after jumping around 6% on Thursday.
  • Jiuzi Holdings, Inc. JZXN fell 13.1% to $8.25.
  • Vertex Pharmaceuticals Incorporated VRTX fell 9.4% to $196.33 after the company reported it "will not advance VX-864 into late-stage development and instead will advance additional novel small."
  • Tyme Technologies, Inc. TYME fell 9.3% to $1.4429 as the company announced a breast cancer trial with Georgetown University named OASIS. Enrollment is expected to start in Q3 of 2021.
  • Orbsat Corp. OSAT fell 8.2% to $5.80 after jumping around 25% on Thursday.
  • Aethlon Medical, Inc. AEMD fell 6.5% to $6.45. Aethlon Medical shares fell 36% on Thursday after the company announced a 1.38 million share registered direct offering priced at $9 per share..
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasHealth CareInformation TechnologyInternet Software & ServicesMid-Day MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!